Microbiotica is a clinical-stage biopharmaceutical company specializing in the development of precision live biotherapeutic products (LBPs) with lead products in immuno-oncology and inflammatory bowel disease. The company leverages a genomics-driven microbiome platform to identify bacterial strains associated with favorable clinical outcomes, enabling the discovery and development of novel therapeutic products. They aim to deliver safe and precise microbiome medicines to benefit patients.